Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 1-2, 2013, Pages 133-136

  Ramos Prol, Agustín ^a   Pérez Lázaro, María Antonia ^b   Del Olmo García, María Isabel ^b   León De Zayas, Beatriz ^b   Moreno Macián, Francisca ^b   Navas De Solis, Soledad ^b   Merino Torres, Juan Francisco ^b  

^a not available   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Antithyroid agents; Attention deficit disorder with hyperactivity; Papillary thyroid cancer; Thyroid hormone resistance syndrome; Triiodothyroacetic acid

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPYLTHIOURACIL; THYROGLOBULIN; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; TIRATRICOL;

ARTICLE; CASE REPORT; CHILD; CODON; DIFFERENTIATED THYROID CANCER; EXON; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GOITER; HEART PALPITATION; HUMAN; MANIA; NERVOUSNESS; SCHOOL CHILD; SIDE EFFECT; TACHYCARDIA; THYROID HORMONE RESISTANCE; WHOLE BODY SCINTISCANNING;

EID: 84878298252     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0230     Document Type: Article

References (24)

1. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 2007;21:277 - 305. (Pubitemid 46888195)
2. Lafranchi SH, Synder DB, Sesser DE, Skeels MR, Singh N, et al. Follow-up of newborns with elevated screening T4 concentrations. J Pediatr 2003;143:296.
3. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993;14:348 - 99. (Pubitemid 23168055)
4. Gurnell M, Halsall DJ, Chatterjee VK. What should be done when thyroid function tests do not make sense ? Clin Endocrinol (Oxf) 2011;74:673 - 8.
5. Beck-Peccoz P, Chatterjee VK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994;4: 225 - 32. (Pubitemid 24202361)
6. Brucker-Davis F, Karulis MC, Grace MB, Benichou J, Hauser P, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med 1995;123:572 - 83.
7. Barkoff MS, Kocherginsky M, Anselmo J, Weiss RE, Refetoff S. Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 2010;95:3189 - 93.
8. Kim HK, Kim D, Yoo EH, Lee JI, Jang HW, et al. A case of resistance to thyroid hormone with thyroid cancer. J Korean Med Sci 2010;25:1368- 71.
9. Paragliola RM, Lovicu RM, Locantore P, Senes P, Concolino P, et al. Differentiated thyroid cancer in two patients with resistance to thyroid hormone. Thyroid 2011;21:793 - 7.
10. Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967;27:279 - 94.
11. Taniyama M, Ishikawa N, Momotani N, Ito K, Ban Y. Toxic multinodular goiter in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor β gene. Clin Endocrinol 2001;54:121 - 4. (Pubitemid 32158714)
12. Siristatidis C, Mastorakos G, Vitoratos N, Gregoriou O, Iakovidou H, et al. Thyroid hormone resistance and enlargement of the sella turcica during pregnancy. Arch Gynecol Obstet 2004;269:152 - 5. (Pubitemid 38146011)
13. Lin KH, Shieh HY, Chen SL, Hsu HC. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 1999;26:53 - 61.
14. Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng S, et al. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett 2000;155:145 - 52. (Pubitemid 30259128)
15. Li Z, Meng ZH, Chandrasekaran R, Kuo WL, Collins CC, et al. Biallelic inactivation of the thyroid hormone receptor β 1 gene in early stage breast cancer. Cancer Res 2002;62:1939 - 43. (Pubitemid 34408433)
16. Horkko TT, Tuppurainen K, George SM, Jernvall P, Karttunen TJ, et al. Thyroid hormone receptor β 1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int J Cancer 2006;118:1653 - 9. (Pubitemid 43376428)
17. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J. Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 2002;87:1120 - 8. (Pubitemid 36121076)
18. Guigon CJ, Cheng SY. Novel oncogenic actions of TR β mutants in tumorigenesis. IUBMB Life 2009;61:528 - 36.
19. Takeda T, Suzuki S, Liu RT, DeGroot LJ. Triiodothyroacetic acid has a unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 1995;80:2033 - 40.
20. Salmela PI, Wide L, Juustila H, Ruokonen A. Effects of thyroid hormones (T4, T3), bromocriptine and Triac on inappropriate TSH hypersecretion. Clin Endocrinol (Oxf) 1988;28:497 - 507.
21. Pohlenz J, Schönberger W, Wemme H, Winterpacht A, Wirth S, et al. New point mutation (R243W) in the hormone binding domain of the c-erbA β1 gene in a family with generalized resistance to thyroid hormone. Hum Mutat 1996;7:79 - 81. (Pubitemid 26002094)
22. Guran T, Turan S, Bircan R, Bereket A. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). J Pediatr Endocrinol Metab 2009;22:971 - 8.
23. Torre P, Bertoli M, Di Giovanni S, Scommegna S, Conte C, et al. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. J Endocrinol Invest 2005;28:657 - 62. (Pubitemid 43162877)
24. Anzai R, Adachi M, Sho N, Muroya K, Asakura Y, et al. Long-term 3,5,3′-triiodothyroacetic acid in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations. Thyroid (in press).